Last reviewed · How we verify

NCT05444868

Validity and Reliability Study of Glittre Activities Of Daily Living Test in Amputees

Completed Last updated 27 December 2023
What this trial tests

trial in Amputation; Traumatic, Limb, Lower in 66 participants. Completed in 10 January 2023.

Timeline
15 July 2022
Primary endpoint
30 December 2022
10 January 2023

Quick facts

Lead sponsorEastern Mediterranean University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment66
Start date15 July 2022
Primary completion30 December 2022
Estimated completion10 January 2023
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Eastern Mediterranean University

Who can join

Adults 18 to 75, any sex, with Amputation; Traumatic, Limb, Lower. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Glittre activities of daily living test is used in different populations. The test, which is valid and reliable in different populations, has not been validated in amputees. In our study, we wanted to investigate the validity and reliability of the Glittre activities of daily living test (Glittre ADL) test in amputees using a lower extremity prosthesis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Amputation; Traumatic, Limb, Lower

Currently open trials in the same condition.

Other Eastern Mediterranean University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05444868.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing